截至2025年4月21日收盘，九洲药业（603456）股价报收13.67元，较前一交易日上涨2.24%。当日开盘后股价震荡上行，最高触及13.93元，最低回探13.21元，全天成交量为24.16万手，成交金额达3.30亿元，换手率为2.70%。公司当前总市值约122.38亿元，市盈率为12.23倍。
公司近期在投资者互动平台表示，2025年一季度CDMO项目数量保持稳健增长，其中处于新药上市申请（NDA）阶段的项目增速较快，为后续商业化生产奠定基础。此外，公司积极参与国际行业展会，包括DCAT Week、CPHI Japan等，持续强化全球业务合作与市场拓展。
风险提示：二级市场股价受多重因素影响，历史表现不预示未来趋势，投资者需谨慎决策。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.